-
Mashup Score: 4CTG Labs - NCBI - 2 year(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: clinicaltrials.govCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3
Click on the article title to read more.
Source: onlinelibrary.wiley.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Job Summary: The Division of Hematology, Oncology and Bone Marrow Transplant within the Department of Pediatrics at the University of Wisconsin School of Medicine and Public Health is recruiting a Bone Marrow Transplant Physician. We are looking for candidates with a track record of clinical excellence and academic contributions as demonstrated through training and/or practice experience in…
Source: jobs.wisc.eduCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2
The FDA approved Lantidra, the first cellular therapy for the treatment of adults with type 1 diabetes.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0UW Health Careers - 2 year(s) agoSource: UW HealthCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Combinatorial fedratinib and venetoclax treatment is effective on human B cell acute lymphoblastic leukemia with high Flt3 expression - 2 year(s) ago
Treatment of relapsed/refractory B cell acute lymphoblastic leukemia (B-ALL) remains a challenge, particularly in patients who do not respond to traditional chemotherapy or immunotherapy. The objective of this study was to assess the efficacy of fedratinib, a semi selective JAK2 inhibitor and venetoclax, a selective BCL-2 inhibitor, on human B-ALL using both single-agent and combinatorial…
Source: bioRxivCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma - 2 year(s) ago
Background: Osteosarcoma (OS) patients that present with metastatic disease have a poor prognosis and no curative options. Allogeneic bone marrow transplant (alloBMT) is curative for hematologic malignancies through the graft-versus-tumor (GVT) effect, but to date has been ineffective for solid tumors like OS. CD155 is expressed on OS and interacts strongly with the inhibitory receptors TIGIT and…
Source: bioRxivCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Pediatric Neuro Oncologist - Madison, Wisconsin, United States - 2 year(s) ago
Job Summary: The Division of Hematology, Oncology and Bone Marrow Transplant within the Department of Pediatrics at the University of Wisconsin School of Medicine and Public Health is recruiting a Pediatric Neuro Oncologist with an interest and expertise in neuro-oncology and neurocutaneous disorders. We are looking for candidates with a track record of clinical excellence and academic…
Source: jobs.wisc.eduCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0FDA Approves Omidubicel-onlv for Hematologic Malignancies - 2 year(s) ago
Patients with hematologic malignancies who require allogenic hematopoietic stem cell transplant can now receive omidubicel following the FDA’s approval of the agent.
Source: Cancer NetworkCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Dexrazoxane confers long-term cardioprotection after anthracyclines for pediatric cancer - 2 year(s) ago
Dexrazoxane appeared to have a cardioprotective effect almost 2 decades after exposure to anthracyclines among a cohort of young adults who survived childhood cancer, according to study results published in Journal of Clinical Oncology.Researchers primarily observed the effect of dexrazoxane among those treated with cumulative doses of doxorubicin of 250 mg/m² or higher.
Source: www.healio.comCategories: Hem/Oncs, Latest HeadlinesTweet
Proud @WiscPediatrics @UWCarbone @UWHealth to be the only US site collaborating with Dr Gray on this innovative trial combining MIBG, anti-PD1 and anti-GD2 #neuroblastoma 1st transatlantic trial #childhoodcancerawarenessmonth https://t.co/MDxJN4tEuJ https://t.co/bZkkqYK2c1